Company Comparison
Tessera Therapeutics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tessera Therapeutics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | — |
| Founded | 2018 | — |
| Status | Active | Active |
| Last Funding Stage | Series B | — |
| Total Funding | $300M | — |
| Valuation | — | — |
What They Build
Tessera Therapeutics
Gene writing company developing a new class of genetic medicines that can write therapeutic messages into the genome to treat or cure diseases.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Tessera Therapeutics and 10x Genomics operate in Biotech.
Browse all Biotech companies →